FindTrial
Sign In

Effect of same cream for different duration.

To study the effect of application duration and dosing frequency on efficacy and adverse effects of topical adapalene in acne vulgaris

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/03/018222
Enrollment
300
Registered
2019-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

Intervention1: Application of topical adapalene accordingly, split face technique: Application of topical adapalene, and follow up every 4 weeks upto 12 weeks Control Intervention1: Application of top

Sponsors

Department of Dermatology and Venereology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Topical adapalene to be applied all over face as advised by split face technique

Exclusion criteria

Exclusion criteria: 1. Pregnant women 2. Breastfeeding women 3. Not giving informed consent 4. Known intolerance to adapalene

Design outcomes

Primary

MeasureTime frame
To reduce lesions of acne within 12 weeksTimepoint: To reduce lesions of acne within 12 weeks—

Secondary

MeasureTime frame
To reduce overall skin irritation and post inflammatory hyperpigmentation of lesions of acneTimepoint: 4 weeks, 8 weeks and 12 weeks—

Countries

India

Contacts

Public ContactPrasanna Kumar Jha

Banaras Hindu University

drsatyendraderma@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026